Previous studies have demonstrated that Nocardia brasiliensis is susceptible to amoxicillin-clavulanic acid and that its I8-lactamases are inhibited in vitro by, clavulanic acid. A cardiac transplant patient with disseminated infection caused by N. brasiliensis was treated with this drug combination with good response, but relapsed while still on therapy. The relapse isolate was found to be identical to the initial isolate by using genomic DNA restriction fragment patterns obtained by pulsed field gel electrophoresis, but it was resistant to amoxicillin-clavulanic acid. On isoelectric focusing, the ,I-lactamase from the relapse isolate exhibited a shift in the isoelectric point (pl) of its major band from 5.10 to 5.04 compared with the enzyme from the pretreatment isolate. As determined by using values of the amount of ,-lactamase inhibitor necessary to give 50 5% inhibition of P-lactamase-mediated hydrolysis of 50 FM nitrocefin, the I8-lactamase of the relapse isolate was also 200-fold more resistant than the enzyme from the pretreatment isolate to clavulanic acid and was more resistant to sulbactam, tazobactam, cloxacillin, and imipenem. The I-lactamase of the relapse isolate exhibited a 10-fold decrease in hydrolytic activity for cephaloridine and other hydrolyzable cephalosporins compared with that for nitrocefin. Acquired resistance to amoxicillin-clavulanic acid in this isolate of N. brasiliensis appears to have resulted from a mutational change affecting the inhibitor and active site(s) in the I8-lactamase.
during amoxicillin-clavulanic acid therapy was found to be highly resistant to all ,-lactamase inhibitors tested, while it exhibited decreased specific activity in crude cell extracts as well as decreased hydrolytic activity against cephalosporins.
MATERIALS AND METHODS
Organisms. Three isolates of N. brasiliensis from a cardiac transplant patient were submitted to the Mycobacteria/ Nocardia Laboratory of The University of Texas Health Center, Tyler, for susceptibility testing. The first isolate, designated Nb-361-1, was recovered from a nodular skin lesion prior to antibiotic therapy. The patient was treated with amoxicillin-clavulanic acid with complete resolution of the skin lesions. After 3 months of therapy, new skin lesions appeared that were culture positive for N. brasiliensis. An isolate from one of these lesions, Nb-361-2, was submitted for susceptibility testing and was found to be resistant to amoxicillin-clavulanic acid. The amoxicillin-clavulanic acid was discontinued and the patient was started on 2 g of ceftriaxone per day. The skin lesions resolved, but then reappeared again when ceftriaxone was discontinued after 3 months of therapy. A third isolate recovered at this time, Nb-361-3, was also submitted for susceptibility testing.
Control organisms included the type strain of N. brasiliensis, ATCC 19296, which was obtained from the American Type Culture Collection (Rockville, Md.); six clinical strains of N. brasiliensis whose ,B-lactamases were previously characterized by isoelectric focusing (22) The ,-lactamases of all three isolates were equally inhibited (67 to 81%) with 0.05 mM p-chloromercuribenzoate.
Isoelectric focusing. The P-lactamase isoelectric focusing patterns of the type strain of N. brasiliensis ATCC 19296 and clinical strains Nb-102, Nb-129, Nb-170, Nb-229, Nb-255, and Nb-264 were identical to the patterns of Nb-361-1 and -3 (22; unpublished data). In contrast, however, the major band of the Nb-361-2 P-lactamase shifted from pI 5.10 to pl 5.04 ( Fig. 1) . This change in isoelectrophoretic mobility, although small, was evident on multiple gels. Additionally, two of the (Fig. 2) . Additionally, all three strains of Nb-361 were found to contain a plasmid of identical electrophoretic mobility. No plasmids were observed in six of the control strains of N. brasiliensis, while one strain contained two plasmids with different electrophoretic mobilities which also differed by their mobilities from the plasmid observed in the three strains of Nb-361.
DISCUSSION
The occurrence of P-lactamase mutants with altered hydrolytic activities has increasingly been described in the literature (5, 10-12, 16, 17, 19, 24) . This is particularly true for the expanding families of TEM and SHV ,-lactamases, which have arisen as the result of single point mutations involving the substitution of one, two, or up to five amino acid moieties (3, 14, 15, 17, 21) . Recently, Manavathu et al. (8) reported an in vitro mutant of the TEM-1 1-lactamase with a 110-fold increase in resistance to clavulanic acid as a result of a single amino acid substitution. These enzyme mutations with altered hydrolytic capabilities also exhibit changes in pIs on isoelectric focusing (4, 5, 8, 14, 17, 21) . In this report we described an in vivo P-lactamase mutation that resulted in resistance to P-lactamase inhibitors and that resembled the in vitro mutation reported by Manavathu et al. (8) . This phenomenon occurred in a highly immunosuppressed patient who was on long-term amoxicillin-clavulanic acid therapy. Previous studies of the P-lactamases of the type strain of N. brasiliensis and the clinical strains Nb-102 and Nb-229 as well as other clinical strains of N. brasiliensis from throughout the United States showed that they were all highly susceptible to clavulanic acid (22) . The 150s for the pretreatment isolate in the current study gave values similar to those reported previously (22 and imipenem. This suggests a similar or identical binding site for all the P-lactamase inhibitors tested.
The genetic mechanism involved in inhibitor resistance resembles the mechanism involved in reduced hydrolytic efficiency described by Philippon et al. (16) for the extendedspectrum ,-lactamases. The 1-lactamase of the N. brasiliensis isolate responsible for a relapse (Nb-361-2) exhibited hydrolytic activities for cephaloridine, cephalothin, cefamandole, and cefoperazone that were 10-fold less than that of the original strain (Nb-361-1). However, the Nb-361-2 P-lactamase differs markedly from the extended-spectrum 3-lactamases in its lack of increased affinity for cephalosporins or penicillins and considerable resistance to inhibitors.
Previous studies have shown that the type strain of N. brasiliensis ATCC 19296 and 82% of clinical strains of N. brasiliensis have the same 1-lactamase pattern on isoelectric focusing (22; unpublished data). Because a single enzyme has been present in all strains studied to date, the gene for this enzyme is almost certainly within the chromosome. The P-lactamase from pre-and posttherapy isolates of Nb-361 had this same common enzyme pattern. The P-lactamase mutation which resulted in inhibitor resistance was accompanied by a small but reproducible shift in the pl of the major band from 5.10 to 5.04 on isoelectric focusing and a comparable shift in two satellite bands. The shift in pIs, the decreased specific activity in crude cell extracts, and most importantly, the reduced cephalosporin hydrolytic activity and resistance to 3-lactamase inhibitors suggest that one or more amino acid substitutions may have occurred at or very close to the enzyme-active site, as has been reported for the extended-spectrum TEM P-lactamases (3, 16 
